日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors

MPS-Authors
/persons/resource/persons214560

Zaiss,  M
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;
Max Planck Institute for Biological Cybernetics, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Zhou, J., Zaiss, M., Knutsson, L., Sun, P., Ahn, S., Aime, S., Bachert, P., Blakeley, J., Cai, K., Chappell, M., Chen, M., Gochberg, D., Goerke, S., Heo, H.-Y., Jiang, S., Jin, T., Kim, S.-G., Laterra, J., Paech, D., Pagel, M., Park, J., Reddy, R., Sakata, A., Sartoretti-Schefer, S., Sherry, A., Smith, S., Stanisz, G., Sundgren, P., Tagao, O., Vandsburger, M., Wen, Z., Wu, Y., Zhang, Y., Zhu, W., Zu, Z., & van Zijl, P. (2022). Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors. Magnetic Resonance in Medicine, 88(2), 546-574. doi:10.1002/mrm.29241.


引用: https://hdl.handle.net/21.11116/0000-000A-588E-4
要旨
Amide proton transfer-weighted (APTw) MR imaging shows promise as a biomarker of brain tumor status. Currently used APTw MRI pulse sequences and protocols vary substantially among different institutes, and there are no agreed-on standards in the imaging community. Therefore, the results acquired from different research centers are difficult to compare, which hampers uniform clinical application and interpretation. This paper reviews current clinical APTw imaging approaches and provides a rationale for optimized APTw brain tumor imaging at 3 T, including specific recommendations for pulse sequences, acquisition protocols, and data processing methods. We expect that these consensus recommendations will become the first broadly accepted guidelines for APTw imaging of brain tumors on 3 T MRI systems from different vendors. This will allow more medical centers to use the same or comparable APTw MRI techniques for the detection, characterization, and monitoring of brain tumors, enabling multi-center trials in larger patient cohorts and, ultimately, routine clinical use.